Toronto, CA (November 25, 2008)—Sanofi-Aventis, one of the world’s leading pharmaceutical companies, recently agreed to a three-year contract to extend the use of Advanced Chemistry Development, Inc., (ACD/Labs) software throughout its R&D sites worldwide. The agreement includes provisions for continuing support, and a special pricing structure beneficial to both companies.

Sanofi-Aventis uses a range of ACD/Labs analytical, predictive, and nomenclature tools such as ACD/SpecManager, ACD/Structure Design Suite, ACD/PhysChem Batch predictors, and ACD/Name. Additional support provided under the new agreement will encourage greater adoption of these tools within all R&D sites, in particular in Europe and the USA. The new contract provides a special pricing model for the company based on the level of deployment throughout the various sites.

“This contract re-negotiation has been innovative in that it allows a higher predictability in the evolution of recurring maintenance and support costs, based on actual yearly usage of ACD/Labs solutions, while at the same time improving the cost-benefits ratio,” said Pascal FREMONT, IS Contract Management. “In addition, although Chemcad’s commercial area is limited to Europe, the contract has been fully globalized thanks to a special agreement from ACD/Labs, thus facilitating the assets management.”

“Sanofi-Aventis has been using ACD/Labs tools in its R&D groups throughout the organization for more than 5 years,” said Yves Lorrain, Director of Sales for Chemcad-a distributor of ACD/Labs products. “With this contract we will continue to provide the same high level of support and allow Sanofi-Aventis R&D scientists to maximize the intrinsic value of each of the ACD/Labs modules they use.” Chemcad is the exclusive distributor of ACD/Labs products for parts of Western Europe, including France, Belgium, Spain, The Netherlands, Sweden, Norway, Finland, and Denmark.

For more information about ACD/Labs and our products please visit our website.

About Advanced Chemistry Development
Advanced Chemistry Development, Inc., (ACD/Labs) is a chemistry software company offering solutions that truly integrate chemical structures with analytical chemistry information to produce ChemAnalytics®. ACD/Labs creates innovative software packages that aid chemical research scientists worldwide with spectroscopic validation of structures, elucidation of unknown substances, chromatographic separation, medicinal chemistry, preformulation of novel drug agents, systematic nomenclature generation, and chemical patenting and publication. Combined, ACD/Labs’ solutions create an analytical informatics system that provides dramatic feed-forward effects on the chemical and pharmaceutical research process. Founded in 1994, and headquartered in Toronto, Canada, ACD/Labs employs a team of over 145 dedicated individuals whose continual efforts carry ACD/Labs’ innovative technologies into pharmaceutical, biotech, chemical, and materials companies throughout the world. Information about Advanced Chemistry Development and its products is available at